Peptide Therapeutics intermediate
Linaclotide - First-in-Human (NCT00434993)
First-in-human trial of linaclotide for IBS-C. This peptide or oligopeptide is studied for its biological activity, structure-activity relationships, and pot...
By Encyclopeptide Editorial | 1 min read
linaclotide-first-in-human-nct00434993 peptide research
Overview
First-in-human trial of linaclotide for IBS-C.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Linaclotide - First-in-Human (NCT00434993)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Linaclotide - First-in-Human (NCT00434993) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept